Estimation of Off-Label Use of XGEVA® (denosumab) Using Population-Based Databases in Denmark (20101335)

15/02/2014
30/03/2024
EU PAS number:
EUPAS5687
Study
Finalised
Documents
Study protocol
Initial protocol
English (870.44 KB - PDF) View document
Study results
Study results
English (27.41 KB - PDF) View document
Study report
Other information